Gen X faces higher cancer risk than Baby Boomers

PHOTO: Freepik

Generation X (Gen X), born between 1965 and 1980, faces a higher risk of developing cancer than the Baby Boomer generation, according to a recent study published in JAMA Network Open.

This comprehensive research, conducted by the National Cancer Institute, analysed the health records of 3.8 million Americans diagnosed with malignant cancer between 1992 and 2018. The findings suggest that as Gen Xers reach the age of 60, starting in 2025, they are more likely to be diagnosed with invasive cancers compared to their predecessors.

The rising cancer rates

The study employed sophisticated computer modelling to project cancer rates and revealed an alarming trend: Generation X is experiencing larger per-capita increases in the incidence of leading cancers than any previous generation born from 1908 through 1964. This increase includes cancers such as thyroid, kidney, rectal, colon, pancreatic, and leukaemia among both men and women. Additionally, women in Gen X are projected to face higher rates of uterine, ovarian, and non-Hodgkin lymphoma, while men may see increases in prostate cancer.

Unexpected findings

Despite significant public health campaigns aimed at reducing cancer risks such as anti-smoking initiatives and increased screenings for colon, rectal, and breast cancers – cancer rates in Gen X continue to rise. The researchers highlighted the importance of understanding how different generations are exposed to varying carcinogens over their lifetimes.

Related news
Gen x cancer
Photo by National Cancer Institute on Unsplash

Contributing factors

The study suggests several reasons for the higher cancer rates in Gen X. One major factor is the rise in obesity and sedentary lifestyles. Additionally, advancements in early detection may also contribute to the increase, as more cancers are diagnosed earlier and more frequently. These factors, combined with lifestyle changes and environmental exposures, paint a complex picture of cancer risk for this generation.

Specific cancer increases

Recent news has already highlighted increases in colorectal cancer among Gen X and younger individuals. However, this study also predicts significant rises in other cancer types. Both men and women in Gen X are likely to see higher rates of thyroid, kidney, and leukaemia cancers. Women, in particular, are projected to face increased risks of uterine, pancreatic, and ovarian cancers, while men may see a rise in prostate cancer.

Generational exposure to carcinogens

The study team emphasised that different generations have been exposed to various potential carcinogens throughout their lives. For instance, a 50-year-old today has encountered a different set of environmental and lifestyle risks compared to someone who was 50 in 1980. These differences in exposures likely contribute to the variations in cancer incidence across generations.

Cancer incidence trends

The study’s lead authors, Dr Philip S. Rosenberg and Dr Adalberto Miranda-Filho, utilised data from the Surveillance, Epidemiology, and End Results (SEER) program to model cancer incidence trends. They focused on invasive cancers diagnosed between ages 35 to 84 from 1992 to 2018, categorising the data by cancer site, sex, race and ethnicity. The analysis showed significant increases in cancer incidence for Gen X compared to Baby Boomers, with notable rises in thyroid, kidney, rectal, colon, and pancreatic cancers among both genders.

Gen x cancer
Image by Tima Miroshnichenko on Pexels

Declines in certain cancers

Interestingly, the study also found decreases in lung and cervical cancer incidence among Gen X women, and declines in lung, liver, gallbladder, and non-Hodgkin lymphoma among men. However, these declines were overshadowed by the increases in other cancer types, resulting in an overall higher cancer incidence for Generation X.

Future projections

The study’s findings suggest that if current trends continue, cancer incidence in the U.S. and even elsewhere around the world could remain high for decades. This poses significant challenges for healthcare systems and underscores the need for continued cancer prevention efforts. The researchers called for further studies to explore the underlying causes of these trends and to develop targeted strategies for reducing cancer risks.

Prevention and lifestyle changes

Preventing cancer remains a critical public health goal. The American Cancer Society, Centers for Disease Control and Prevention, and World Health Organization advocate for several preventive measures, including reducing tobacco and alcohol use, increasing physical activity, improving dietary habits, and promoting breastfeeding. These actions not only lower cancer risk but also contribute to overall health improvements.

Gen x cancer
Photo by Kristaps Solims on Unsplash

Looking ahead

As Millennials (born 1981-1996) approach middle age, there are concerns about their future cancer risk. The study’s projections for Gen X raise questions about the potential cancer burden for younger generations. However, advancements in cancer research and prevention offer hope for mitigating these risks. Continued investment in public health initiatives and cancer prevention strategies will be crucial in addressing this growing challenge.

The findings of this study emphasise the importance of understanding generational differences in cancer risk and the need for targeted prevention efforts. With Gen X facing higher cancer rates than previous generations, public health initiatives must continue to evolve to address the changing landscape of cancer risk. By focusing on lifestyle changes, early detection, and addressing health disparities, we can work towards reducing the cancer burden for future generations.

Individuals who are in the Generation X age bracket are strongly recommended to undergo frequent cancer screenings and to also get an experienced oncologist to oversee their health as it is better to prevent or detect cancer at the early stages rather than at later more serious phases. Contact MyMediTravel, the leading global medical concierge.


Dr. Nikhil Prasad

Dr. Nikhil Prasad is an independent researcher, medical, pharma and health PR consultant, herbalists and phytochemical specialists and a medical and health writer for numerous international publications and sites including his own sites such as Thailand Medical News. He is based either at Sydney, New York, Shanghai, Mumbai or Bangkok.

Related Articles